Blar i HV - Fakultet for helsevitenskap ansatte på tidsskrift "Orphanet Journal of Rare Diseases"
Viser treff 1-1 av 1
-
Effectiveness and safety of everolimus treatment in patients with tuberous sclerosis complex in real-world clinical practice
(Peer reviewed; Journal article, 2023)Background The randomised double‑blinded placebo‑controlled EXIST‑1–3 studies have showed everolimus effective with adverse effects reported as acceptable in treatment of symptoms in patients with tuberous sclerosis complex ...